ストックスクリーナーアプリを入手
33.85
0.92%
0.33
Alkermes Plc (ALKS) 最新ニュース
Alkermes stock price target raised to $47 from $46 at UBS on Avadel deal - Investing.com
Corvus Pharmaceuticals Stock Rallies 209% in a Month: Here's Why - Finviz
Why analysts are rating Alkermes (ALKS) a buy - MSN
Jim Cramer on Alkermes: "I Think It's a Hold, Maybe a Weak One" - Finviz
Jim Cramer on Alkermes: “I Think It’s a Hold, Maybe a Weak One” - Insider Monkey
Weekly Earnings: Is Alkermes plc benefiting from interest rate changesQuarterly Trade Report & Verified Entry Point Detection - baoquankhu1.vn
ImmunityBio Stock Soars on FDA Talks for Anktiva sBLA Resubmission - Finviz
NVO Expands Aspect Tie-Up to Advance Curative Diabetes Cell Therapies - Finviz
Campbell & CO Investment Adviser LLC Has $741,000 Position in Alkermes plc $ALKS - MarketBeat
Precision Trading with Alkermes Plc (ALKS) Risk Zones - Stock Traders Daily
Jim Cramer Says Sell Super Micro — Calls A European Chipmaker 'Cheap And Good' - Sahm
Avadel Sets Court Date for Alkermes Acquisition Scheme - TipRanks
Avadel (NASDAQ: AVDL) moves Alkermes acquisition forward with Irish court hearing date - Stock Titan
ImmunityBio Shares Surge on Updated Durable Lymphoma Study Results - Finviz
Alkermes (ALKS) Is Up 6.8% After FDA Breakthrough Tag for Narcolepsy Drug Candidate AlixorextonWhat's Changed - simplywall.st
Aug Outlook: Is Braemar Hotels Resorts Inc part of any ETF2025 Trading Recap & Fast Entry Momentum Trade Alerts - baoquankhu1.vn
Alkermes Receives FDA Breakthrough Therapy Designation for Alixorexton, Potentially Accelerating Development - Intellectia AI
Alkermes (ALKS) Is Up 6.6% After FDA Breakthrough Tag for Narcolepsy Drug Alixorexton - Yahoo Finance
Rate Cut: What analysts say about Alkermes plc stockTrade Performance Summary & High Accuracy Swing Trade Signals - baoquankhu1.vn
Aug Final Week: Is Alkermes plc benefiting from interest rate changesJobs Report & Short-Term High Return Ideas - baoquankhu1.vn
Recap Report: Can Alkermes plc stock outperform in a bear market - baoquankhu1.vn
Erasca Stock Surges 42% in a Week: Here's What You Should Know - Finviz
ALKS: RBC Capital Raises Price Target to $47, Maintains 'Outperf - GuruFocus
Piper Sandler Raises Price Target for ALKS to $45, Reiterates Ov - GuruFocus
Are Medical Stocks Lagging Alkermes (ALKS) This Year? - sharewise.com
Avadel Pharmaceuticals shareholders approve $2.37B takeover bid - The Business Journals
Apellis Stock Crashes 23% in a Week: Here's What You Should Know - Finviz
Alkermes PLC (ALKS) Stock Price Up 3.16% on Jan 15 - GuruFocus
Alkermes (NASDAQ:ALKS) Rating Increased to Strong-Buy at Zacks Research - MarketBeat
Alkermes plc (NASDAQ:ALKS) Receives Average Rating of "Moderate Buy" from Brokerages - MarketBeat
Will Alkermes (ALKS) Beat Estimates Again in Its Next Earnings Report? - Finviz
Best Value Stocks to Buy for Jan.14 - The Globe and Mail
Update Report: Can inTEST Corporation scale operations efficientlySell Signal & Real-Time Chart Pattern Alerts - baoquankhu1.vn
Improved Earnings Required Before Alkermes Plc (NASDAQ:ALKS) Shares Find Their Feet - 富途牛牛
Aug Rallies: Will Alkermes plc stock remain a Wall Street favorite2025 Volume Leaders & Momentum Based Trading Ideas - Bộ Nội Vụ
Retail Trends: Can Alkermes plc stock deliver 10 annual returnsInsider Selling & Precise Trade Entry Recommendations - Bộ Nội Vụ
Avadel Shareholders Approve Acquisition by Alkermes - Sleep Review
Alkermes Touts $10B Sleep Market as ALKS 2680 Heads to Phase 3, Avidel Deal Nears Close - Yahoo Finance
ALKS: ALKS 2680 advances to Phase 3, targeting major sleep disorders and expanding commercial reach - TradingView — Track All Markets
ALKS: ALKS 2680 advances as a potential blockbuster, driving growth and sleep medicine expansion - TradingView — Track All Markets
Avadel shareholders approve acquisition by Alkermes - Investing.com Nigeria
Alkermes (ALKS) Secures Shareholder Approval for Avadel Acquisition - GuruFocus
Avadel shareholders approve acquisition by Alkermes By Investing.com - Investing.com South Africa
Avadel Shareholders Approve Acquisition by Alkermes plc - TipRanks
Avadel Pharmaceuticals Announces that Avadel Shareholders Approve the Proposed Acquisition by Alkermes - The Manila Times
Avadel Pharmaceuticals plc Approves Scheme of Arrangement for Alkermes Acquisition - Quiver Quantitative
Shareholders back Avadel sale to Alkermes after strong vote - Stock Titan
Alkermes plans Avadel acquisition to expand sleep portfolio - TipRanks
Alkermes plc (ALKS): Investor Outlook Reveals 47.29% Potential Upside Amid Robust Product Pipeline - DirectorsTalk Interviews
How to contact the Daily Bulletin - FinancialContent
Buybacks Report: What dividend safety score for Alkermes plc stock2025 Key Highlights & Smart Swing Trading Techniques - Bộ Nội Vụ
Is Alkermes plc (8AK) stock a momentum leaderJuly 2025 Weekly Recap & Stepwise Swing Trade Plans - ulpravda.ru
Is Alkermes plc stock positioned for digital transformation2025 Growth vs Value & Capital Protection Trade Alerts - Улправда
What dividend safety score for Alkermes plc stockMarket Sentiment Review & High Yield Equity Trading Tips - Улправда
Technical Reactions to ALKS Trends in Macro Strategies - Stock Traders Daily
Workboat Indexes - FinancialContent
Top Biotech Players REGN, INCY, PTCT Among Participants At J.P.Morgan Healthcare Conference 2026 - RTTNews
How FDA Breakthrough Therapy Status for Alixorexton Will Impact Alkermes (ALKS) Investors - Sahm
2.12%
0.47%
大文字化:
|
ボリューム (24 時間):